CombiGene AB's total assets for Q4 2024 were kr75.88M, a decrease of -16.78% from the previous quarter. DE:COJ0 total liabilities were kr4.30M for the fiscal quarter, a -21.07% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.